Titan Pharmaceuticals, Inc. Current Liabilities
Titan Pharmaceuticals, Inc. had Current Liabilities of $263.00 thousand as of 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2025-08-14
- 2025-06-30: Liabilities, Current $263.00K.
- 2025-03-31: Liabilities, Current $279.00K.
- 2024-12-31: Liabilities, Current $483.00K.
- 2024-09-30: Liabilities, Current $371.00K.
| Period end | Liabilities, Current |
|---|---|
| 2025-06-30 | $263.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $279.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $483.00K 10-Q · filed 2025-08-14 |
| 2024-09-30 | $371.00K 10-Q · filed 2025-01-03 |
| 2024-06-30 | $356.00K 10-Q · filed 2024-08-15 |
| 2024-03-31 | $559.00K 10-Q · filed 2024-05-15 |
| 2023-12-31 | $1.44M 10-K · filed 2025-03-20 |
| 2023-09-30 | $1.87M 10-K · filed 2024-04-01 |
| 2023-06-30 | $1.85M 10-Q · filed 2023-08-14 |
| 2023-03-31 | $2.45M 10-Q · filed 2023-05-15 |
| 2022-12-31 | $2.63M 10-K · filed 2024-04-01 |
| 2022-09-30 | $2.63M 10-Q · filed 2022-11-14 |
| 2022-06-30 | $2.52M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $2.28M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $2.67M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.93M 10-Q · filed 2021-11-15 |
| 2021-06-30 | $2.52M 10-Q · filed 2021-08-16 |
| 2021-03-31 | $3.76M 10-Q · filed 2021-05-17 |
| 2020-12-31 | $4.22M 10-K · filed 2022-03-25 |
| 2020-09-30 | $5.88M 10-Q · filed 2020-11-16 |
| 2020-06-30 | $4.86M 10-Q · filed 2020-08-14 |
| 2020-03-31 | $4.41M 10-Q · filed 2020-05-15 |
| 2019-12-31 | $3.60M 10-K · filed 2021-03-31 |
| 2019-09-30 | $3.48M 10-Q · filed 2019-11-14 |
| 2019-06-30 | $4.34M 10-Q · filed 2019-08-14 |
| 2019-03-31 | $4.76M 10-Q · filed 2019-05-15 |
| 2018-12-31 | $3.45M 10-K · filed 2020-03-30 |
| 2018-09-30 | $2.20M 10-Q · filed 2018-11-14 |
| 2018-06-30 | $2.39M 10-Q · filed 2018-08-14 |
| 2018-03-31 | $2.72M 10-Q · filed 2018-05-15 |
| 2017-12-31 | $4.46M 10-K/A · filed 2019-04-02 |
| 2017-09-30 | $1.97M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $1.87M 10-Q · filed 2017-08-09 |
| 2017-03-31 | $2.27M 10-Q · filed 2017-05-10 |
| 2016-12-31 | $4.86M 10-K · filed 2018-04-02 |
| 2016-09-30 | $6.72M 10-Q · filed 2016-11-09 |
| 2016-06-30 | $6.07M 10-Q · filed 2016-08-09 |
| 2016-03-31 | $5.08M 10-Q · filed 2016-05-10 |
| 2015-12-31 | $4.85M 10-K · filed 2017-03-16 |
| 2015-09-30 | $4.59M 10-Q · filed 2015-11-16 |
| 2015-06-30 | $5.29M 10-Q · filed 2015-08-13 |
| 2015-03-31 | $5.34M 10-Q · filed 2015-05-13 |
| 2014-12-31 | $6.66M 10-K · filed 2016-03-15 |
| 2014-09-30 | $7.46M 10-Q · filed 2014-11-13 |
| 2014-06-30 | $7.82M 10-Q · filed 2014-08-13 |
| 2014-03-31 | $9.16M 10-Q · filed 2014-05-14 |
| 2013-12-31 | $10.85M 10-K · filed 2015-03-31 |
| 2013-09-30 | $12.25M 10-Q · filed 2013-11-14 |
| 2013-06-30 | $13.53M 10-Q · filed 2013-08-14 |
| 2013-03-31 | $19.98M 10-Q · filed 2013-05-15 |
| 2012-12-31 | $21.39M 10-K · filed 2014-03-31 |
| 2012-09-30 | $10.89M 10-Q · filed 2012-11-09 |
| 2012-06-30 | $9.46M 10-Q · filed 2012-08-09 |
| 2012-03-31 | $5.89M 10-Q · filed 2012-05-10 |
| 2011-12-31 | $5.12M 10-K · filed 2013-03-18 |
| 2011-09-30 | $6.38M 10-Q · filed 2011-11-14 |
| 2011-06-30 | $6.21M 10-Q/A · filed 2011-08-17 |
| 2010-12-31 | $5.41M 10-K · filed 2012-03-15 |